Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label ExtensionRenato Mantegazza, Maria da Penha Ananias Morita, Kenji P. Fujita et al.|Neurology|2020Cited by 80
Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Érica Nogueira Coelho, Renato Mantegazza et al.|Quality of Life Research|2019Cited by 58